JCM
FBT icon

Jacobi Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Jacobi Capital Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Hold
1,399
– – 0.02% 545
2025
Q4 		$289K Buy
+1,399
New +$280K 0.02% 538
2025
Q3 		– Sell
-1,374
Closed -$222K – 598
2025
Q2 		$222K Sell
1,374
-20
-1% -$3.19K 0.01% 558
2025
Q1 		$237K Sell
1,394
-16
-1% -$2.78K 0.02% 522
2024
Q4 		$234K Buy
1,410
+8
+0.6% +$1.37K 0.02% 532
2024
Q3 		$241K Hold
1,402
– – 0.02% 517
2024
Q2 		$216K Sell
1,402
-52
-4% -$7.8K 0.02% 487
2024
Q1 		$224K Hold
1,454
– – 0.02% 447
2023
Q4 		$230K Sell
1,454
-700
-32% -$101K 0.02% 426
2023
Q3 		$315K Sell
2,154
-30
-1% -$4.57K 0.04% 344
2023
Q2 		$334K Sell
2,184
-49
-2% -$7.64K 0.04% 341
2023
Q1 		$346K Hold
2,233
– – 0.04% 328
2022
Q4 		$344K Hold
2,233
– – 0.04% 320
2022
Q3 		$295K Hold
2,233
– – 0.04% 337
2022
Q2 		$303K Buy
2,233
+46
+2% +$6.34K 0.04% 333
2022
Q1 		$326K Buy
2,187
+39
+2% +$5.77K 0.04% 331
2021
Q4 		$348K Hold
2,148
– – 0.04% 328
2021
Q3 		$357K Hold
2,148
– – 0.05% 310
2021
Q2 		$371K Hold
2,148
– – 0.05% 287
2021
Q1 		$345K Buy
2,148
+12
+0.6% +$2.06K 0.05% 273
2020
Q4 		$359K Hold
2,136
– – 0.06% 248
2020
Q3 		$336K Hold
2,136
– – 0.06% 231
2020
Q2 		$358K Hold
2,136
– – 0.07% 221
2020
Q1 		$280K Sell
2,136
-39
-2% -$5.56K 0.06% 220
2019
Q4 		$323K Sell
2,175
-52
-2% -$7.14K 0.06% 236
2019
Q3 		$276K Buy
2,227
+24
+1% +$3.19K 0.05% 243
2019
Q2 		$310K Sell
2,203
-83
-4% -$11.5K 0.06% 234
2019
Q1 		$345K Sell
2,286
-120
-5% -$17.3K 0.09% 164
2018
Q4 		$299K Buy
2,406
+142
+6% +$19.4K 0.08% 171
2018
Q3 		$359K Buy
2,264
+81
+4% +$12.3K 0.1% 134
2018
Q2 		$306K Hold
2,183
– – 0.09% 144
2018
Q1 		$276K Sell
2,183
-10
-0.5% -$1.36K 0.08% 136
2017
Q4 		$277K Sell
2,193
-13
-0.6% -$1.61K 0.09% 133
2017
Q3 		$278K Buy
+2,206
New +$261K 0.09% 111

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Jacobi Capital Management's FBT Position: Q1 2026 in Review

Jacobi Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 1,399 shares worth $281K. The position accounts for 0.02% of the portfolio, ranked #545.

Jacobi Capital Management first reported a position in FBT in Q3 2017 and has held it in 34 quarters since. The position peaked at $371K in Q2 2021. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Jacobi Capital Management held 1,399 shares of First Trust NYSE Arca Biotechnology Index Fund worth $281K as of Q1 2026.
  • Jacobi Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Jacobi Capital Management's portfolio in Q1 2026, its #545 holding.
  • Jacobi Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and has held it in 34 quarters since.
  • Jacobi Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $371K in Q2 2021.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.